REFERENCES

1. Xu HX. Contrast-enhanced ultrasound: The evolving applications. World J Radiol. 2009;1:15-24.

2. Malone CD, Fetzer DT, Monsky WL, et al. Contrast-enhanced US for the interventional radiologist: current and emerging applications. Radiographics. 2020;40:562-88.

3. Correas JM, Bridal L, Lesavre A, Méjean A, Claudon M, Hélénon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol. 2001;11:1316-28.

4. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med. 2008;29:28-44.

5. Ali MT, Johnson M, Irwin T, et al. Incidence of severe adverse drug reactions to ultrasound enhancement agents in a contemporary echocardiography practice. J Am Soc Echocardiogr. 2024;37:276-284.e3.

6. Piscaglia F, Bolondi L. Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006;32:1369-75.

7. Cui Q, Dai L, Li J, et al. Contrast-enhanced ultrasound-guided sentinel lymph node biopsy in early-stage breast cancer: a prospective cohort study. World J Surg Oncol. 2023;21:143.

8. Muskula PR, Main ML. Safety with echocardiographic contrast agents. Circ Cardiovasc Imaging. 2017;10:e005459.

9. Hao Y, Sun Y, Lei Y, Zhao H, Cui L. Percutaneous sonazoid-enhanced ultrasonography combined with in vitro verification for detection and characterization of sentinel lymph nodes in early breast cancer. Eur Radiol. 2021;31:5894-901.

10. Sever AR, Mills P, Jones SE, et al. Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer. AJR Am J Roentgenol. 2011;196:251-6.

11. Sever A, Jones S, Cox K, Weeks J, Mills P, Jones P. Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasonography in patients with breast cancer. Br J Surg. 2009;96:1295-9.

12. Li JS, Crane CN, Santucci RA. Vaginoplasty tips and tricks. Int Braz J Urol. 2021;47:263-73.

13. Xie F, Zhang D, Cheng L, et al. Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer. World J Surg Oncol. 2015;13:319.

14. Xiahou Y, Yuan X, Zhu J, Hu W, Zhang L. The significance of contrast-enhanced ultrasound in the application of lymphaticovenous anastomosis. Curr Med Imaging. 2023; doi: 10.2174/0115734056273626231120112216.

15. Zhu J, Yu X, Zhang L, Liu Z. Lymphography using microbubbles and contrast-enhanced ultrasound (CEUS) before lymphatic supermicrosurgery for severe lymphorrhea of lower extremity. J Plast Reconstr Aesthet Surg. 2023;84:537-9.

16. Jang S, Lee CU, Hesley GK, Knudsen JM, Brinkman NJ, Tran NV. Lymphatic mapping using us microbubbles before lymphaticovenous anastomosis surgery for lymphedema. Radiology. 2022;304:218-24.

17. Lahtinen O, Eloranta M, Anttila M, et al. Preoperative sentinel lymph node localization in vulvar cancer: preliminary experience with inguinal intradermal contrast-enhanced ultrasound. Eur Radiol. 2018;28:2089-95.

18. Jang S, Bustos SS, Chen AD, et al. Lymphatic mapping with contrast-enhanced ultrasound for lymphaticovenous anastomosis surgery: how we do it. Plast Reconstr Surg Glob Open. 2023;11:e5328.

19. Jang S, Rames JD, Hesley GK, et al. Randomized feasibility study evaluating multiple fda-approved microbubbles for CEUS lymphography. Plast Reconstr Surg Glob Open. 2024;12:e5985.

20. United States Food and Drug Administration. Definity prescribing information. Published online June 2023. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021064.

21. United States Food and Drug Administration. Optison prescribing information. Published online September 2021. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020899.

22. United States Food and Drug Administration. Lumason prescribing information. Published online April 2021. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203684.

23. Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol. 2009;193:86-95.

24. Sridharan A, Eisenbrey JR, Forsberg F, Lorenz N, Steffgen L, Ntoulia A. Ultrasound contrast agents: microbubbles made simple for the pediatric radiologist. Pediatr Radiol. 2021;51:2117-27.

25. Sirsi S, Borden M. Microbubble compositions, properties and biomedical applications. Bubble Sci Eng Technol. 2009;1:3-17.

26. Ntoulia A, Back SJ, Darge K. Contrast-enhanced ultrasound in children: a first-of-its-kind comprehensive compendium! Pediatr Radiol. 2021;51:2115-6.

27. Goldberg BB, Merton DA, Liu JB, et al. Contrast-enhanced ultrasound imaging of sentinel lymph nodes after peritumoral administration of Sonazoid in a melanoma tumor animal model. J Ultrasound Med. 2011;30:441-53.

28. Li J, Lu M, Cheng X, et al. How pre-operative sentinel lymph node contrast-enhanced ultrasound helps intra-operative sentinel lymph node biopsy in breast cancer: initial experience. Ultrasound Med Biol. 2019;45:1865-73.

29. Rames JD, Tran NV, Hesley GK, Fahradyan V, Lee CU. An allergic reaction in contrast-enhanced ultrasound lymphography for lymphovenous bypass surgery. Plast Reconstr Surg Glob Open. 2024;12:e5908.